Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis — Stella

Home/MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease/Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

View on ClinicalTrials.gov

Recruiting

Back to MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trials

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Washington, Seattle, Washington

Key details

Sponsor

ContextVision AB

Collaborators

University of Washington

Enrollment target

~110 participants

Started

November 2025

Primary completion

October 2026

Age range

18 Years – 75 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.